FindTrial
Sign In

Effect of oxygenation in ICU patients with ARDS by inhaled Amikacin and its evaluation.

Evaluation of effects on oxygenation in terms of PaO2/FiO2 ratio by inhaled Amikacin in critically ill ARDS patients:A Double blinded Quasi experimental study. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/104550
Enrollment
70
Registered
2026-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00-J99- Diseases of the respiratory system

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

Dr Ram Manohar Lohia Institute Of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Ready to give written consent by legally acceptable relative. 2. Diagnosis of moderate to severe ARDS (Global Definition of ARDS 2024). 3. Patient requiring oxygen therapy (NIV, Venturi mask, mechanical invasive ventilation).

Exclusion criteria

Exclusion criteria: 1. Known allergy to aminoglycosides. 2. Severe obstructive lung disease. 3. Pregnant and lactating women. 4. Acute kidney injury or Chronic kidney disease. 5. If patients were receiving systemic aminoglycoside therapy. 6. Participation in other interventional trials.

Design outcomes

Primary

MeasureTime frame
Improving Pao2/FiO2 ratio in terms of length of stay in ICU and 28 days mortality in critically ill patients with ARDSTimepoint: 28 days.—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Abdur Rehman Malik

DR Ram Manohar Lohia Institute of medical sciences

georgian.manojt@gmail.com7607286685

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026